HUNTINGTON DISEASE
Clinical trials for HUNTINGTON DISEASE explained in plain language.
Never miss a new study
Get alerted when new HUNTINGTON DISEASE trials appear
Sign up with your email to follow new studies for HUNTINGTON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Huntington's drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested a drug called PTC518 in 159 adults with Huntington's disease to see if it is safe and can lower a harmful protein in the blood. Participants received different doses of the drug or a placebo for up to 12 months. The goal is to slow disease progression by targeti…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a cooking oil protect the brain in Huntington's?
Disease control CompletedThis study tested whether a special oil called triheptanoin can slow brain damage in people with early Huntington's disease. 100 participants took either the oil or a placebo for 6 months, followed by 6 months where everyone got the oil. The main goal was to see if it reduced bra…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Huntington's drug shows promise in small safety trial
Disease control CompletedThis early-phase study tested a new drug called ER2001 in 8 adults with early Huntington's disease. The main goal was to check if the drug is safe and tolerable when given repeatedly through an IV. Researchers also looked at how the drug moves through the body and if it shows any…
Matched conditions: HUNTINGTON DISEASE
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New Huntington's drug shows promise in early safety trial
Disease control CompletedThis early phase 1 trial tested an experimental drug called ER2001 in 10 adults with early Huntington's disease. The drug was given by IV at increasing doses over 14 weeks to check safety and how the body processes it. The study also looked for early signs that the drug might aff…
Matched conditions: HUNTINGTON DISEASE
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a common diabetes drug protect the brain in Huntington's?
Disease control CompletedThis study tested whether metformin, a widely used diabetes drug, can slow the loss of thinking skills in people with Huntington's disease. Sixty adults took either metformin or a placebo for one year. Researchers measured changes in memory, attention, and other cognitive functio…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE3 • Sponsor: Instituto de Investigacion Sanitaria La Fe • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could stem cells slow Huntington's? new trial tests cellavita HD
Disease control CompletedThis phase 2 trial tested a stem cell therapy called Cellavita HD in 49 people with Huntington's disease. Participants received either a low dose, high dose, or placebo through IV infusions over several months. The study measured changes in motor skills to see if the treatment co…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2 • Sponsor: Azidus Brasil • Aim: Disease control
Last updated Jun 26, 2026 18:55 UTC
-
New Huntington's drug candidate SAGE-718 enters first human safety tests
Disease control CompletedThis early-stage trial tested the safety and tolerability of an experimental drug called SAGE-718 in 6 healthy adults and a small group of people with Huntington's disease. Researchers looked for side effects and measured how the drug moves through the body. The goal was to see i…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE1 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:54 UTC
-
Beat the blues: drumming classes show promise for Parkinson's and Huntington's
Symptom relief CompletedThis study tested whether group drumming classes could improve quality of life and motor skills in people with Parkinson's or Huntington's disease. Eighteen participants took drum lessons twice a week for 12 weeks. Researchers measured changes in anxiety, depression, hand functio…
Matched conditions: HUNTINGTON DISEASE
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Dancing away Huntington's: study tests if movement improves mind and body
Symptom relief CompletedThis study looked at whether taking weekly dance classes for 8 months can help people with Huntington's disease and their caregivers. Researchers measured movement control, emotion, quality of life, and brain changes using tests and MRI scans. The goal was to see if dance trainin…
Matched conditions: HUNTINGTON DISEASE
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Can virtual reality boost brain power in movement disorders?
Symptom relief CompletedThis study tested whether using immersive virtual reality or computer-based brain training could improve thinking and memory in people with Parkinson's or Huntington's disease who have mild cognitive problems. Sixty-four participants were randomly assigned to one of three groups:…
Matched conditions: HUNTINGTON DISEASE
Phase: NA • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New drug aims to sharpen thinking in Huntington's patients
Symptom relief CompletedThis study tested whether SAGE-718, an experimental oral drug, can improve cognitive function in people with early Huntington's disease. 69 participants took either the drug or a placebo for 28 days. The main goal was to measure changes in thinking skills using a battery of cogni…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 17:02 UTC
-
Blood test could spot Parkinson's earlier, study hopes
Knowledge-focused CompletedThis completed study looked for specific gene patterns in the blood that could help diagnose Parkinson's disease and distinguish it from similar conditions. Researchers analyzed blood samples and brain scans from 219 people with Parkinson's or related disorders. The goal is to de…
Matched conditions: HUNTINGTON DISEASE
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Brain energy test in huntington patients shows no treatment yet
Knowledge-focused CompletedThis study looked at how the brain uses energy in people with early Huntington disease. Ten adults had an MRI scan to measure brain energy levels while resting and watching flashing lights. The goal was to understand brain metabolism, not to test a new treatment.
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Could your morning coffee slow Huntington's?
Knowledge-focused CompletedThis study looked at whether caffeine intake is linked to how Huntington's disease progresses in people who have the gene but not yet symptoms. Researchers followed 77 participants, measuring brain volume changes and thinking skills over time. The goal was to see if caffeine migh…
Matched conditions: HUNTINGTON DISEASE
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Huntington disease survey aims to make clinical trials more Participant-Friendly
Knowledge-focused CompletedThis completed survey study asked 131 people with or at risk for Huntington disease about their feelings, attitudes, and beliefs toward clinical research. The goal is to help researchers design better studies that are more aware of participants' needs. No treatment or drug was te…
Matched conditions: HUNTINGTON DISEASE
Sponsor: Huntington Study Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Brain energy levels tracked in huntington disease study
Knowledge-focused CompletedThis study looked at how brain energy changes in people with Huntington disease. Researchers used a special MRI technique to measure energy-related chemicals in the brain. The goal was to understand the disease better, not to test a treatment. About 50 adults with early-stage Hun…
Matched conditions: HUNTINGTON DISEASE
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC